Translatome analysis reveals altered serine and glycine metabolism in T-cell acute lymphoblastic leukemia cells.
Animals
Cell Line
Gene Expression Profiling
Glycine
/ metabolism
Mice
Mutation
Phosphoric Monoester Hydrolases
Polyribosomes
/ genetics
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
/ genetics
Protein Biosynthesis
RNA, Messenger
/ genetics
Ribosomal Protein L10
Ribosomal Proteins
/ genetics
Ribosomes
/ metabolism
Sequence Analysis, RNA
Serine
/ metabolism
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
11 06 2019
11 06 2019
Historique:
received:
31
01
2018
accepted:
10
05
2019
entrez:
13
6
2019
pubmed:
13
6
2019
medline:
5
7
2019
Statut:
epublish
Résumé
Somatic ribosomal protein mutations have recently been described in cancer, yet their impact on cellular transcription and translation remains poorly understood. Here, we integrate mRNA sequencing, ribosome footprinting, polysomal RNA sequencing and mass spectrometry datasets from a mouse lymphoid cell model to characterize the T-cell acute lymphoblastic leukemia (T-ALL) associated ribosomal RPL10 R98S mutation. Surprisingly, RPL10 R98S induces changes in protein levels primarily through transcriptional rather than translation efficiency changes. Phosphoserine phosphatase (PSPH), encoding a key serine biosynthesis enzyme, was the only gene with elevated transcription and translation leading to protein overexpression. PSPH upregulation is a general phenomenon in T-ALL patient samples, associated with elevated serine and glycine levels in xenograft mice. Reduction of PSPH expression suppresses proliferation of T-ALL cell lines and their capacity to expand in mice. We identify ribosomal mutation driven induction of serine biosynthesis and provide evidence supporting dependence of T-ALL cells on PSPH.
Identifiants
pubmed: 31186416
doi: 10.1038/s41467-019-10508-2
pii: 10.1038/s41467-019-10508-2
pmc: PMC6559966
doi:
Substances chimiques
RNA, Messenger
0
Ribosomal Proteins
0
Rpl10 protein, mouse
0
Serine
452VLY9402
Phosphoric Monoester Hydrolases
EC 3.1.3.2
phosphoserine phosphatase
EC 3.1.3.3
Glycine
TE7660XO1C
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2542Subventions
Organisme : EC | EC Seventh Framework Programm | FP7 Ideas: European Research Council (FP7-IDEAS-ERC - Specific Programme: "Ideas" Implementing the Seventh Framework Programme of the European Community for Research, Technological Development and Demonstration Activities (2007 to 2013))
ID : 334946
Pays : International
Organisme : Stichting Tegen Kanker (Belgian Foundation Against Cancer)
ID : 2012-176
Pays : International
Organisme : Stichting Tegen Kanker (Belgian Foundation Against Cancer)
ID : 2016-775
Pays : International
Organisme : Stichting Tegen Kanker (Belgian Foundation Against Cancer)
ID : 2016-801
Pays : International
Organisme : Onderzoeksraad, KU Leuven (Research Council, KU Leuven)
ID : C14/18/104
Pays : International
Références
J Mass Spectrom. 1996 Mar;31(3):255-62
pubmed: 8799277
Science. 2009 Apr 10;324(5924):218-23
pubmed: 19213877
Blood. 2012 Nov 1;120(18):3764-73
pubmed: 22976955
Nat Genet. 2013 Feb;45(2):186-90
pubmed: 23263491
Gynecol Oncol. 2013 Mar;128(3):470-4
pubmed: 23127973
Genome Biol. 2013 Apr 25;14(4):R36
pubmed: 23618408
Int Immunol. 2008 Mar;20(3):421-31
pubmed: 18270368
Cancer Cell. 2011 Apr 12;19(4):484-97
pubmed: 21481790
Trends Biochem Sci. 2014 Apr;39(4):191-8
pubmed: 24657017
PLoS Genet. 2013;9(12):e1003997
pubmed: 24367274
Hum Mutat. 2014 Dec;35(12):1442-5
pubmed: 25196364
Sci Adv. 2016 Oct 28;2(10):e1601273
pubmed: 27819051
Haematologica. 2017 Aug;102(8):e317-e320
pubmed: 28428269
Genome Biol. 2012 Dec 13;13(12):R115
pubmed: 23237666
Genome Biol. 2009;10(3):R25
pubmed: 19261174
Cell Cycle. 2007 Apr 1;6(7):843-52
pubmed: 17361108
Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6726-30
pubmed: 8341691
Bioinformatics. 2013 Dec 1;29(23):2995-3002
pubmed: 24048356
Nucleic Acids Res. 2013 Jul;41(Web Server issue):W77-83
pubmed: 23703215
Nat Protoc. 2012 Jul 26;7(8):1534-50
pubmed: 22836135
Vaccines (Basel). 2016 Aug 06;4(3):
pubmed: 27509527
Leukemia. 2018 Mar;32(3):809-819
pubmed: 28744013
PLoS Comput Biol. 2014 Jul 24;10(7):e1003731
pubmed: 25058159
Genome Biol. 2014;15(12):550
pubmed: 25516281
Haematologica. 2017 Sep;102(9):1605-1616
pubmed: 28659337
Cell. 2011 Nov 11;147(4):789-802
pubmed: 22056041
J Cell Biol. 1999 Oct 4;147(1):121-34
pubmed: 10508860
Cell. 2016 Feb 11;164(4):757-69
pubmed: 26871635
Leukemia. 2017 Aug;31(8):1706-1714
pubmed: 27909306
Blood. 2017 Mar 2;129(9):1113-1123
pubmed: 28115373
Biochem Biophys Res Commun. 1997 Jan 13;230(2):331-4
pubmed: 9016777
Nat Genet. 2017 Aug;49(8):1211-1218
pubmed: 28671688
Blood. 2013 Jul 4;122(1):74-82
pubmed: 23687089
Cell Metab. 2017 Feb 7;25(2):345-357
pubmed: 28111214
Oncotarget. 2017 Feb 28;8(9):14462-14478
pubmed: 28147343
Cancer Discov. 2017 Oct;7(10):1069-1087
pubmed: 28923911
PLoS One. 2016 Sep 28;11(9):e0163328
pubmed: 27681508
Nat Commun. 2018 Apr 10;9(1):1368
pubmed: 29636461
Cell Rep. 2014 Sep 11;8(5):1365-79
pubmed: 25159147
Leukemia. 2019 Feb;33(2):319-332
pubmed: 29930300
Proc Natl Acad Sci U S A. 2014 Apr 15;111(15):5640-5
pubmed: 24706786
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Cell Res. 2015 Apr;25(4):429-44
pubmed: 25793315
Nature. 2017 Jun 15;546(7658):426-430
pubmed: 28607489
Nat Genet. 2013 Mar;45(3):242-52
pubmed: 23334668
RNA Biol. 2017 Oct 3;14(10):1299-1305
pubmed: 28277937
Nat Rev Cancer. 2016 Oct;16(10):650-62
pubmed: 27634448
Nature. 2011 Aug 18;476(7360):346-50
pubmed: 21760589
J Immunol. 2010 Apr 1;184(7):3433-41
pubmed: 20181882